11 news items
Gilead Provides Update on Phase 3 TROPiCS-04 Study
GILD
30 May 24
treatment options to help improve long-term outcomes.
Gilead would like to thank the patients, families
Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024
GILD
22 May 24
the long-term efficacy and safety profile of investigational seladelpar for the treatment of primary biliary cholangitis (PBC
Gilead's Recently Acquired Liver Disease Candidate Shows Improvements In Disease Progression And Associated Itch
GILD
20 May 24
ASSURE study.
The ASSURE study is an open-label study to evaluate the long-term safety
Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
GILD
18 May 24
Conference in Washington, DC.
ASSURE is an open-label study evaluating the long-term safety and efficacy
Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024
GILD
7 May 24
-up in an adult-only study of a CAR T-cell therapy for R/R B-cell lymphoblastic leukemia (B-ALL). These data continue to support the long-term survival
93gsvyczd3isfgx5427f3mxjr9xry11ocnb0y2jh1hefobs5h6
GILD
25 Apr 24
and timing of Veklury revenues; Gilead's ability to make progress on any of its long-term ambitions or priorities laid out in its corporate strategy
pr9hhgy0p0tuhmiiwi363ugskgotq7knqcs87anj85hfhvxb1vsp405093s3
AZN
GILD
GTHX
11 Apr 24
Index® (BCI) test, which demonstrably led to physicians changing their long-term anti-estrogen treatment recommendations
lw00fha32hstak3e2c7z71536f36xi5schsjcjf1so1 ylctylb
GILD
6 Mar 24
of long-term evidence for Biktarvy and reinforce Gilead's commitment to a person-centric approach to HIV treatment research."
HIV
b5817v7eizp5d wzo4by0
GILD
6 Mar 24
Clinical Development, Gilead Sciences. "The data presented at CROI contribute to the growing body of long-term evidence for Biktarvy and reinforce
zcq dnx0nk1uwaum5mca5efj59lckwvhog7z6ko5u8r9mggcmys1kmgp
GILD
MRK
6 Mar 24
treatment is not one size fits all – developing once-weekly treatment options could help meet the needs of each individual, aiming toward maximizing long
9mxn3vut7fh2rlm1wl3km78dv95d9u2z
GILD
MRK
6 Mar 24
maximizing long-term outcomes for people with HIV," said Jared Baeten, Vice President, MD, PhD, HIV Clinical Development, Gilead Sciences
- Prev
- 1
- Next